---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-000107"
form_type: "8-K"
ticker: "PASG"
cik: "0001787297"
company_name: "Passage BIO, Inc."
filed_at: "2024-01-05T23:59:59+00:00"
generated_at: "2026-06-07T03:16:52.536178+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Passage Bio furnishes updated corporate presentation; no specific milestones or financials disclosed

## Summary
- Corporate presentation furnished as Exhibit 99.1 under Item 7.01 Regulation FD.
- Filing does not contain any new financial results, pipeline updates, or guidance changes.
- Presentation is not deemed filed for SEC liability purposes and is not incorporated by reference.
- No material operational or strategic changes apparent from the filing text alone.

## SEC filing metadata
- accession: 0001558370-24-000107
- form_type: 8-K
- ticker: PASG
- cik: 0001787297
- company_name: Passage BIO, Inc.
- filed_at: 2024-01-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787297/000155837024000107/0001558370-24-000107-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787297/000155837024000107/pasg-20240105x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-000107
- JSON: https://secwatch.observer/filing/0001558370-24-000107.json
- Plain text: https://secwatch.observer/filing/0001558370-24-000107.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.